{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T16:25:58Z","timestamp":1793895958828,"version":"4.8.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100016971","name":"Lomonosov Moscow State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016971","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["22\\u201315-00098-P"],"award-info":[{"award-number":["22\\u201315-00098-P"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bioorg.2026.110122","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:49:53Z","timestamp":1781711393000},"page":"110122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Structure\u2013property relationships of benzyl-substituted urea-based ligands with Phe-Phe linker targeting prostate-specific membrane antigen labeled with gallium-68"],"prefix":"10.1016","volume":"180","author":[{"given":"Nina S.","family":"Butakova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislav A.","family":"Petrov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasiia A.","family":"Uspenskaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolay Y.","family":"Zyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander S.","family":"Lunev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina A.","family":"Petrosova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iurii A.","family":"Mitrofanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marat G.","family":"Rakhimov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergei A.","family":"Evteev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan A.","family":"Ivanenkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena A.","family":"Demidova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vadim S.","family":"Pokrovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena K.","family":"Beloglazkina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton A.","family":"Larenkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksei E.","family":"Machulkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.110122_bb0005","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0140-6736(24)00651-2","article-title":"The lancet commission on prostate cancer: planning for the surge in cases","volume":"403","author":"James","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.bioorg.2026.110122_bb0010","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bioorg.2026.110122_bb0015","doi-asserted-by":"crossref","DOI":"10.1134\/S1070363225605721","article-title":"Organic chemistry in the creation of molecules with practically useful properties","volume":"96","author":"Belyakova","year":"2026","journal-title":"Russ. J. Gen. Chem."},{"key":"10.1016\/j.bioorg.2026.110122_bb0020","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1111\/bph.13576","article-title":"The therapeutic and diagnostic potential of the prostate specific membrane antigen\/glutamate carboxypeptidase II (PSMA\/GCPII) in cancer and neurological disease","volume":"173","author":"Evans","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.110122_bb0025","doi-asserted-by":"crossref","first-page":"9755","DOI":"10.3390\/ijms25179755","article-title":"Prostate-specific membrane antigen biology and pathophysiology in prostate carcinoma, an update: potential implications for targeted imaging and therapy","volume":"25","author":"Maes","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110122_bb0030","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1091\/mbc.e02-11-0731","article-title":"A novel cytoplasmic tail MXXXL motif mediates the internalization of prostate-specific membrane antigen","volume":"14","author":"Rajasekaran","year":"2003","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bioorg.2026.110122_bb0035","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/jamaoncol.2019.0096","article-title":"Assessment of 68Ga-PSMA-11 PET accuracy in localizing recurrent prostate cancer: a prospective single-arm clinical trial","volume":"5","author":"Fendler","year":"2019","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.bioorg.2026.110122_bb0040","doi-asserted-by":"crossref","unstructured":"O. Sartor, J. de Bono, K.N. Chi, K. Fizazi, K. Herrmann, K. Rahbar, S.T. Tagawa, VISION investigators, Lutetium-177\u2013PSMA-617 for metastatic castration-resistant prostate cancer, N. Engl. J. Med. 385 (2021) 1091\u20131103. doi:https:\/\/doi.org\/10.1056\/NEJMoa2107322.","DOI":"10.1056\/NEJMoa2107322"},{"key":"10.1016\/j.bioorg.2026.110122_bb0045","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1021\/mp900069d","article-title":"Prostate-specific membrane antigen targeted imaging and therapy of prostate cancer using a PSMA inhibitor as a homing ligand","volume":"6","author":"Kularatne","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bioorg.2026.110122_bb0050","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1021\/mp9000712","article-title":"Design, synthesis, and preclinical evaluation of prostate-specific membrane antigen targeted 99mTc-radioimaging agents","volume":"6","author":"Kularatne","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bioorg.2026.110122_bb0055","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s10517-016-3490-3","article-title":"Nanohybrid materials based on magnetite-gold nanoparticles for diagnostics of prostate cancer: synthesis and in vitro testing","volume":"161","author":"Machulkin","year":"2016","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.bioorg.2026.110122_bb0060","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3390\/magnetochemistry8120185","article-title":"Bifunctional magnetite\u2013gold nanoparticles for magneto-mechanical actuation and cancer cell destruction","volume":"8","author":"Garanina","year":"2022","journal-title":"Magnetochemistry"},{"key":"10.1016\/j.bioorg.2026.110122_bb0065","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1021\/acs.jmedchem.5b01210","article-title":"Preclinical evaluation of a tailor-made DOTA-conjugated PSMA inhibitor with optimized linker for imaging and therapy","volume":"59","author":"Bene\u0161ov\u00e1","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110122_bb0070","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.2967\/jnumed.115.158550","article-title":"68Ga- and 177Lu-labeled PSMA I&T: optimization of a PSMA-targeted theranostic concept and first proof-of-concept human studies","volume":"56","author":"Weineisen","year":"2015","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.bioorg.2026.110122_bb0075","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s41181-022-00180-1","article-title":"Good practices for 68Ga radiopharmaceutical production","volume":"7","author":"Nelson","year":"2022","journal-title":"EJNMMI Radiopharm. Chem"},{"key":"10.1016\/j.bioorg.2026.110122_bb0080","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/ejic.201900706","article-title":"The use of the macrocyclic chelator DOTA in radiochemical separations","author":"Baranyai","year":"2020","journal-title":"Eur. J. Inorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110122_bb0085","doi-asserted-by":"crossref","first-page":"10960","DOI":"10.1021\/ic101378s","article-title":"Gallium(III) complexes of DOTA and DOTA-monoamide: kinetic and thermodynamic studies","volume":"49","author":"Kub\u00ed\u010dek","year":"2010","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110122_bb0090","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1021\/acsptsci.1c00035","article-title":"Lipophilicity determines routes of uptake and clearance, and toxicity of an alpha-particle-emitting peptide receptor radiotherapy","volume":"4","author":"Tafreshi","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.bioorg.2026.110122_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118433","article-title":"A series of conjugates based on prostate-specific membrane antigen ligands with the chelating agent DOTA: synthesis, radiolabeling, and biological activity","volume":"303","author":"Butakova","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110122_bb0100","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1021\/acsptsci.4c00070","article-title":"Synthesis and preclinical evaluation of urea-based prostate-specific membrane antigen-targeted conjugates labeled with 177Lu","volume":"7","author":"Machulkin","year":"2024","journal-title":"ACS Pharmacol. Transl. Sci"},{"key":"10.1016\/j.bioorg.2026.110122_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.128840","article-title":"Synthesis and initial in vitro evaluation of PSMA-targeting ligands with a modified aromatic moiety at the lysine \u03b5-nitrogen atom","volume":"71","author":"Zyk","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110122_bb0110","first-page":"4455","article-title":"Synthesis and biological evaluation of PSMA-targeting urea-based radioconjugates for radiotheranostics of prostate cancer","volume":"64","author":"Machulkin","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110122_bb0115","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00044-022-03002-w","article-title":"Optimization of the dipeptide motifs in the PSMA ligands linker structure: synthesis and in vitro evaluation","volume":"32","author":"Uspenskaya","year":"2023","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2026.110122_bb0120","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10967-015-4089-2","article-title":"Preparation of highly purified 68Ga solutions via ion exchange in hydrochloric acid\u2013ethanol mixtures","volume":"305","author":"Larenkov","year":"2015","journal-title":"J. Radioanal. Nucl. Chem."},{"key":"10.1016\/j.bioorg.2026.110122_bb0125","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10967-019-06964-1","article-title":"Determination of ionic 68Ga impurity in radiopharmaceuticals: major revision of radio-HPLC methods","volume":"323","author":"Maruk","year":"2020","journal-title":"J. Radioanal. Nucl. Chem."},{"key":"10.1016\/j.bioorg.2026.110122_bb0130","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: new docking methods, expanded force field, and python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2026.110122_bb0135","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF chimera\u2014a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2026.110122_bb0140","first-page":"33","article-title":"On the protection of animals used for scientific purposes","volume":"276","author":"Directive 2010\/63\/EU of the European Parliament and of the Council of 22 September 2010","year":"2010","journal-title":"Off. J. Eur. Union L"},{"key":"10.1016\/j.bioorg.2026.110122_bb0145","doi-asserted-by":"crossref","first-page":"8264","DOI":"10.7150\/thno.45537","article-title":"A new class of PentixaFor- and PentixaTher-based theranostic agents with enhanced CXCR4-targeting efficiency","volume":"10","author":"Osl","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.bioorg.2026.110122_bb0150","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/j.bmcl.2019.06.035","article-title":"Synthesis and biological evaluation of PSMA-targeting paclitaxel conjugates","volume":"29","author":"Machulkin","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110122_bb0155","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1021\/cr300177k","article-title":"Photoremovable protecting groups in chemistry and biology: reaction mechanisms and efficacy","volume":"113","author":"Kl\u00e1n","year":"2013","journal-title":"Chem. Rev."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110122_bb0160","first-page":"81","article-title":"Prostate-specific membrane antigen expression in normal and malignant human tissues","volume":"3","author":"Silver","year":"1997","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2026.110122_bb0165","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s00268-005-0544-5","article-title":"Expression of prostate-specific membrane antigen in normal and malignant human tissues","volume":"30","author":"Kinoshita","year":"2006","journal-title":"World J. Surg."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110122_bb0170","doi-asserted-by":"crossref","first-page":"849","DOI":"10.7150\/thno.14744","article-title":"Towards personalized treatment of prostate cancer: PSMA I&T, a promising prostate-specific membrane antigen-targeted theranostic agent","volume":"6","author":"Chatalic","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.bioorg.2026.110122_bb0175","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1007\/s00259-024-07044-7","article-title":"JHU-2545 preferentially shields salivary glands and kidneys during PSMA-targeted imaging","volume":"52","author":"Nedelcovych","year":"2025","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826006589?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826006589?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T15:46:13Z","timestamp":1793893573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826006589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":35,"alternative-id":["S0045206826006589"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110122","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure\u2013property relationships of benzyl-substituted urea-based ligands with Phe-Phe linker targeting prostate-specific membrane antigen labeled with gallium-68","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110122","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110122"}}